Persistent Pulmonary Hypertension of the Newborn
📧 Sign up to get email alerts when something new happens for Persistent Pulmonary Hypertension of the Newborn.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-04-05FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)
FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC to update its labeling.